All Featured Insights

Shutdown ends, Moody’s outlook for not-for-profit hospitals for 2026, Canada loses measles elimination status.

Signs of interest in federal regulation of health AI, new warning issued about antibiotic resistance, White House announces drug pricing deal.

CBO finds OBBB could lead to Medicare cuts, employers expecting major healthcare cost increases in 2026, competing immunization guidelines.

UnitedHealth’s difficulties continue, more doctors exit traditional Medicare, troubling new report on hospital safety reporting

All ACIP committee members dismissed, dozens of states sue 23andMe, FDA to use AI in drug approvals

CBO releases coverage impacts of One Big Beautiful Bill, 5th Circuit to rehear No Surprises Act challenge, many Epic customers live on TEFCA.

Trump administration continues transparency push, Hinge Health’s splash IPO, CMS looks for Medicare Advantage fraud.

UnitedHealth Group stock drops, eight artificial food dyes to be phased out, Eli Lilly oral GLP-1 pill has promising Phase 3 result

NIH makes cuts to administrative funds, House GOP seeks to make large healthcare spending cuts, some federal healthy agencies’ webpages restored.

RFK Jr. clears Senate panel, federal and state policy battle over transgender care comes to head in New York, Moody’s downgrades health insurer credit outlook

OMB memo causes significant confusion, Change cyberattack affected 190 million people, Cigna to limit out-of-pocket drug costs.

Next round of drugs for Medicare drug price negotiations announced, Trump health policy actions in second term, ACA exchanges see record enrollment in 2025